17-Jan-2026
Download PDF
Mangalam Drugs
Disclosure Pursuant to Regulation 30 Schedule III Part A Para 7(B) of SEBI(LODR) Regulations 2015 for resignation of Mr. Rukmesh P. Dhandhania -Independent Director of the Company.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
